Your browser doesn't support javascript.
loading
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.
Lochmann, Timothy L; Floros, Konstantinos V; Naseri, Mitra; Powell, Krista M; Cook, Wade; March, Ryan J; Stein, Giovanna T; Greninger, Patricia; Maves, Yuki Kato; Saunders, Laura R; Dylla, Scott J; Costa, Carlotta; Boikos, Sosipatros A; Leverson, Joel D; Souers, Andrew J; Krystal, Geoffrey W; Harada, Hisashi; Benes, Cyril H; Faber, Anthony C.
Afiliación
  • Lochmann TL; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia.
  • Floros KV; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia.
  • Naseri M; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia.
  • Powell KM; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia.
  • Cook W; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia.
  • March RJ; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Stein GT; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Greninger P; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Maves YK; Crown Bioscience Inc, San Diego, California.
  • Saunders LR; AbbVie Stemcentrx LLC, South San Francisco, California.
  • Dylla SJ; AbbVie Stemcentrx LLC, South San Francisco, California.
  • Costa C; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
  • Boikos SA; Division of Hematology, Oncology, & Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.
  • Leverson JD; AbbVie, North Chicago, Illinois.
  • Souers AJ; AbbVie, North Chicago, Illinois.
  • Krystal GW; Department of Internal Medicine, Virginia Commonwealth University, McGuire Veterans Affairs Medical Center, Richmond, Virginia.
  • Harada H; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia. acfaber@vcu.edu cbenes@mgh.harvard.edu hharada@vcu.edu.
  • Benes CH; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts. acfaber@vcu.edu cbenes@mgh.harvard.edu hharada@vcu.edu.
  • Faber AC; VCU Philips Institute, School of Dentistry and Massey Cancer Center; Richmond, Virginia. acfaber@vcu.edu cbenes@mgh.harvard.edu hharada@vcu.edu.
Clin Cancer Res ; 24(2): 360-369, 2018 01 15.
Article en En | MEDLINE | ID: mdl-29118061
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Expresión Génica / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Expresión Génica / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article